Navidea Biopharmaceuticals Inc Receita T/T
Qual é o Receita T/T de Navidea Biopharmaceuticals Inc?
O Receita T/T de Navidea Biopharmaceuticals Inc é N/A
Qual é a definição de Receita T/T?
O crescimento trimestral da receita, ano após ano, é o aumento da receita de uma empresa em comparação com o desempenho no trimestre correspondente do ano anterior, expresso como uma porcentagem.
Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.
O que Navidea Biopharmaceuticals Inc faz?
navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de